Michael Kauffman - Director, Verastem, Inc
As of June 30, 2021
Michael Kauffman Net Worth
- Net worth is estimated to be at least $32.28M
- Owns at least 8,000 units of Verastem, Inc stock
- Sold an estimated value of $23.57K in the last 9 years at Verastem, Inc
Michael Kauffman Trading
- Largest purchase of shares was 8,000 units , worth over $29.96K on October 2, 2018
- Largest sale of shares was 3,000 units , worth over $23.57K on February 17, 2016
- In total has made about 12 transactions over 9 years
- Usually trades in June, with the busiest year in 2014 and 2016
Michael Kauffman
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Michael Kauffman Mailing Address
- Mailing address is C/o Karyopharm Therapeutics Inc. 85 Wells Avenue, Second Floor Newton MA 02459 MA
Verastem, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Brian M. Stuglik | 2020 | $609,231 | $1,274,700 | $1,039,353 | $507,000 | $42,390 | $3,472,674 |
Brian M. Stuglik | 2019 | $253,846 | $386,100 | $943,643 | $200,000 | $133,605 | $1,917,194 |
Daniel Paterson | 2020 | $467,077 | $928,807 | $693,132 | $299,000 | $14,030 | $2,402,046 |
Daniel Paterson | 2019 | $445,269 | - | $1,056,352 | $230,000 | $4,551 | $1,736,172 |
Robert Gagnon | 2020 | $421,385 | $706,490 | $347,109 | $215,800 | $14,030 | $1,704,814 |
Robert Gagnon | 2019 | $396,365 | $181,000 | $829,650 | $176,000 | $14,280 | $1,597,295 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1526119/000155837021004084/tmb-20210518xdef14a.htm
Verastem, Inc Insider Trading
- The most recent transaction was 4,988 units sold on May 17, 2022 by Dan Paterson worth over $5.14K
- In the last 10 years, insiders at Verastem, Inc sold an estimated value of $8.15M and bought an estimated value of $38.1M
- The most active traders are Dan Paterson, President and COO, Christoph Westphal, Executive Chairman, and Robert Forrester, President and CEO
- Insider trading is most common in June, with the busiest year in 2013
Verastem, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |